• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物识别的人类气道细胞模型中跨膜蛋白的邻近图谱分析

BioID-Based Proximity Mapping of Transmembrane Proteins in Human Airway Cell Models.

作者信息

Iazzi Melissa, Astori Audrey, St-Germain Jonathan, Sadeghi Sara, Raught Brian, Gupta Gagan D

机构信息

Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, ON, Canada.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

出版信息

Methods Mol Biol. 2025;2908:51-64. doi: 10.1007/978-1-0716-4434-8_4.

DOI:10.1007/978-1-0716-4434-8_4
PMID:40304902
Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel residing primarily at the apical membrane of epithelial cells, plays a major role in fluid secretion and the maintenance of epithelial surface hydration. Mutations in the CFTR gene lead to the fatal disease known as cystic fibrosis (CF). Drugs that improve mutant CFTR protein folding and channel function have dramatically improved CF patient outcomes. However, the current regimen only restores the function of the most common mutant, ΔF508, to ~62% of wildtype (WT). Notably, ~10% of patients harboring hundreds of less common CFTR mutations are not eligible or do not respond at all to treatment with current CFTR modulators. Better characterizing the WT and mutant CFTR protein interactomes could provide critical insight into how to treat patients with rarer mutations and thereby improve the druggability of this devastating disease. Here we describe how BioID (proximity-dependent biotin identification) can be used to map the CFTR interactome in a human airway model-bronchial epithelial cells grown at the air-liquid interface. Approximately 26% (>5500) of all human protein-coding genes are predicted to code for membrane proteins, which together account for ~30% of the druggable proteome. The methods described here could thus also be applied to improve our understanding of many additional respiratory, autoimmune, and metabolic diseases.

摘要

囊性纤维化跨膜传导调节因子(CFTR)是一种主要位于上皮细胞顶端膜的氯离子通道,在液体分泌和上皮表面水合作用的维持中起主要作用。CFTR基因突变会导致致命疾病——囊性纤维化(CF)。改善突变型CFTR蛋白折叠和通道功能的药物显著改善了CF患者的预后。然而,目前的治疗方案仅将最常见的突变体ΔF508的功能恢复到野生型(WT)的约62%。值得注意的是,约10%携带数百种较不常见CFTR突变的患者不符合当前CFTR调节剂治疗的条件或对其完全无反应。更好地描述野生型和突变型CFTR蛋白相互作用组可以为如何治疗罕见突变患者提供关键见解,从而提高这种毁灭性疾病的可药物化性。在这里,我们描述了如何使用BioID(邻近依赖性生物素识别)来绘制人气道模型——在气液界面生长的支气管上皮细胞中的CFTR相互作用组。预计所有人类蛋白质编码基因中约26%(>5500个)编码膜蛋白,它们共同占可药物化蛋白质组的约30%。因此,这里描述的方法也可用于增进我们对许多其他呼吸道、自身免疫和代谢疾病的理解。

相似文献

1
BioID-Based Proximity Mapping of Transmembrane Proteins in Human Airway Cell Models.基于生物识别的人类气道细胞模型中跨膜蛋白的邻近图谱分析
Methods Mol Biol. 2025;2908:51-64. doi: 10.1007/978-1-0716-4434-8_4.
2
Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.上皮钠离子通道沉默作为纠正囊性纤维化气道表面液体缺陷的策略。
Am J Respir Cell Mol Biol. 2013 Sep;49(3):445-52. doi: 10.1165/rcmb.2012-0408OC.
3
The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells.在极化的人气道上皮细胞中,挽救的ΔF508-囊性纤维化跨膜传导调节因子(CFTR)的顶端膜半衰期较短,这是由于ΔF508-CFTR的内吞作用加速所致。
J Biol Chem. 2005 Nov 4;280(44):36762-72. doi: 10.1074/jbc.M508944200. Epub 2005 Aug 30.
4
Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation.囊性纤维化跨膜电导调节蛋白调节上皮细胞对曲霉的反应及由此产生的肺部炎症。
Am J Respir Crit Care Med. 2012 Feb 1;185(3):301-10. doi: 10.1164/rccm.201106-1027OC. Epub 2011 Dec 1.
5
Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.通过 SLC6A14 依赖性氨基酸摄取增强人支气管上皮细胞中的囊性纤维化跨膜电导调节剂功能。对囊性纤维化治疗的启示。
Am J Respir Cell Mol Biol. 2019 Dec;61(6):755-764. doi: 10.1165/rcmb.2019-0094OC.
6
Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells.钠/氢交换调节因子同工型1的过表达调节人气道16HBE14o-细胞中囊性纤维化跨膜传导调节因子(CFTR)的表达和活性,并挽救囊性纤维化细胞中DeltaF508 CFTR的功能表达。
J Biol Chem. 2005 Dec 9;280(49):40925-33. doi: 10.1074/jbc.M505103200. Epub 2005 Oct 3.
7
Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.Tgf-β1 抑制 Cftr 的生物发生,防止功能性拯救原发性分化人支气管上皮细胞中的 ΔF508-Cftr。
PLoS One. 2013 May 9;8(5):e63167. doi: 10.1371/journal.pone.0063167. Print 2013.
8
Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.铜绿假单胞菌对囊性纤维化跨膜电导调节因子功能的有害影响及其在气道上皮细胞中的恢复。
Eur Respir J. 2015 Jun;45(6):1590-602. doi: 10.1183/09031936.00076214. Epub 2015 Mar 18.
9
Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.囊性纤维化跨膜传导调节因子(CFTR)的周转:永生化气道上皮细胞表面膜制剂中野生型和ΔF508 CFTR的缓慢降解
J Cell Physiol. 1996 Aug;168(2):373-84. doi: 10.1002/(SICI)1097-4652(199608)168:2<373::AID-JCP16>3.0.CO;2-4.
10
Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).低温和化学拯救影响 DeltaF508-囊性纤维化跨膜电导调节因子 (CFTR) 和上皮钠通道 (ENaC) 的分子接近度。
J Biol Chem. 2012 May 11;287(20):16781-90. doi: 10.1074/jbc.M111.332031. Epub 2012 Mar 22.

本文引用的文献

1
Proximity Mapping of Ciliary Proteins by BioID.通过生物识别技术对纤毛蛋白进行邻近映射
Methods Mol Biol. 2024;2725:181-198. doi: 10.1007/978-1-0716-3507-0_11.
2
A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome.囊性纤维化跨膜电导调节蛋白表面蛋白组学研究。
Int J Mol Sci. 2023 Jul 14;24(14):11457. doi: 10.3390/ijms241411457.
3
Membrane Proteins: Structure, Function and Motion.膜蛋白:结构、功能与运动。
Int J Mol Sci. 2022 Dec 27;24(1):468. doi: 10.3390/ijms24010468.
4
Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters.差异型 CFTR 相互作用组邻近标记程序鉴定多种 SLC 转运蛋白的富集情况。
Int J Mol Sci. 2022 Aug 11;23(16):8937. doi: 10.3390/ijms23168937.
5
Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants.不同的蛋白稳态状态驱动囊性纤维化跨膜电导调节子错误折叠突变体对药物伴侣的敏感性。
Mol Biol Cell. 2022 Jun 1;33(7):ar62. doi: 10.1091/mbc.E21-11-0578. Epub 2022 Apr 7.
6
Proximity Profiling of the CFTR Interaction Landscape in Response to Orkambi.奥马卡尼治疗后 CFTR 相互作用图谱的临近分析
Int J Mol Sci. 2022 Feb 23;23(5):2442. doi: 10.3390/ijms23052442.
7
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system.使用哺乳动物膜双杂交高通量筛选系统进行 CFTR 相互作用组图谱绘制。
Mol Syst Biol. 2022 Feb;18(2):e10629. doi: 10.15252/msb.202110629.
8
Pulmonary Alveolar Microlithiasis - A Review.肺肺泡微结石症——综述。
Yale J Biol Med. 2021 Dec 29;94(4):637-644. eCollection 2021 Dec.
9
Small-molecule drugs for cystic fibrosis: Where are we now?用于治疗囊性纤维化的小分子药物:我们目前处于什么阶段?
Pulm Pharmacol Ther. 2022 Feb;72:102098. doi: 10.1016/j.pupt.2021.102098. Epub 2021 Nov 15.
10
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease.依伐卡托与泰比卡托和艾氟康唑三联疗法治疗三例携带 Phe508del/未知基因型和晚期肺部疾病的囊性纤维化患者的疗效。
Genes (Basel). 2021 Jul 29;12(8):1178. doi: 10.3390/genes12081178.